HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis.

AbstractBACKGROUND:
Polyglutamine (polyQ) diseases are dominant neurodegenerative diseases caused by an expansion of the polyQ-encoding CAG repeats in the disease-causing gene. The length of the CAG repeats is the major determiner of the age at onset (AO) of polyQ diseases, including Huntington's disease (HD) and spinocerebellar ataxia type 3 (SCA3).
OBJECTIVE:
We set out to identify common genetic variant(s) that may affect the AO of polyQ diseases.
METHODS:
Three hundred thirty-seven patients with HD or SCA3 were enrolled for targeted sequencing of 583 genes implicated in proteinopathies. In total, 16 genes were identified as containing variants that are associated with late AO of polyQ diseases. For validation, we further investigate the variants of PIAS1 because PIAS1 is an E3 SUMO (small ubiquitin-like modifier) ligase for huntingtin (HTT), the protein linked to HD.
RESULTS:
Biochemical analyses revealed that the ability of PIAS1S510G to interact with mutant huntingtin (mHTT) was less than that of PIAS1WT , resulting in lower SUMOylation of mHTT and lower accumulation of insoluble mHTT. Genetic knock-in of PIAS1S510G in a HD mouse model (R6/2) ameliorated several HD-like deficits (including shortened life spans, poor grip strength and motor coordination) and reduced neuronal accumulation of mHTT.
CONCLUSIONS:
Our findings suggest that PIAS1 is a genetic modifier of polyQ diseases. The naturally occurring variant, PIAS1S510G , is associated with late AO in polyQ disease patients and milder disease severity in HD mice. Our study highlights the possibility of targeting PIAS1 or pathways governing protein homeostasis as a disease-modifying approach for treating patients with HD. © 2021 International Parkinson and Movement Disorder Society.
AuthorsYan Hua Lee, Yu-Shuen Tsai, Che-Chang Chang, Chun-Chen Ho, Hsiu-Ming Shih, Hui-Mei Chen, Hsing-Lin Lai, Chia-Wei Lee, Yi-Chung Lee, Yi-Chu Liao, Ueng-Cheng Yang, Tzu-Hao Cheng, Yijuang Chern, Bing-Wen Soong
JournalMovement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 37 Issue 4 Pg. 767-777 (04 2022) ISSN: 1531-8257 [Electronic] United States
PMID34951052 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 International Parkinson and Movement Disorder Society.
Chemical References
  • Huntingtin Protein
  • PIAS1 protein, human
  • Peptides
  • Pias1 protein, mouse
  • Protein Inhibitors of Activated STAT
  • Small Ubiquitin-Related Modifier Proteins
  • polyglutamine
  • Ligases
Topics
  • Animals
  • Disease Models, Animal
  • Humans
  • Huntingtin Protein (genetics)
  • Huntington Disease (genetics, metabolism)
  • Ligases (metabolism)
  • Mice
  • Peptides
  • Protein Inhibitors of Activated STAT (genetics, metabolism)
  • Proteostasis
  • Small Ubiquitin-Related Modifier Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: